Related Experiment Video
Updated: May 30, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
[Evidence-based cardiology: practical applications from epidemiology. II. The use of biomarkers]
Jorge F Trejo-Gutiérrez1, Francisco López-Jiménez
1Division of Cardiovascular Diseases, Mayo Clinic Florida.
Abstract:
The use of biomarkers that show an association with the development of cardiovascular disease needs a careful evaluation in regard to the quality of evidence that establishes their relationship. Although observational studies have been paramount to establish the importance of the traditional risk factors, we can only screen and intervene on biomarkers when there is demonstrated benefit in well-designed randomized clinical trials.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Introduction to Epidemiology
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
